Isocitrate dehydrogenase 1/2 mutations are almost mutually exclusive in AML, as only rare cases (<0.5%) harbor both IDH1 and IDH2 mutations (Abbas et al., 2010; Paschka et al., 2010; Green et al., 2011). The gene discussed is IDH2; the disease is acute myeloid leukemia.